{
    "nctId": "NCT05411432",
    "briefTitle": "Clinical Study of 68Ga Labeled HER2 Affibody Analogues",
    "officialTitle": "Clinical Study of 68Ga Labeled HER2 Affibody Analogues in Healthy Volunteers and Patients With Breast or Gastric Tumors",
    "overallStatus": "UNKNOWN",
    "conditions": "HER2-positive Breast Cancer and Gastric Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "EARLY_PHASE1",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 56,
    "primaryOutcomeMeasure": "SUV of organs",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* patients with breast or gastric cancers: diagnosed by MR and ready for surgery\n\nExclusion Criteria:\n\n* refuse or cannot endure surgery pregnant women",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}